Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,414,242
-$671,749 QoQ
Shares Held
12,190
-15.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#905
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Choate Investment Advisors holds $157,042,184 across 12 Drug Manufacturers - General names. AMGN ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,791 | $60,920,254 | |
| 2 | JNJ |
Johnson & Johnson
|
184,823 | $46,939,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,634 | $18,025,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,736 | $12,173,576 | |
| 5 | NVS |
Novartis AG
|
29,237 | $4,582,022 | |
| 6 | AMGN |
Amgen Inc
This page
|
12,190 | $4,414,242 | |
| 7 | PFE |
Pfizer Inc
|
142,810 | $3,438,864 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
42,788 | $2,465,444 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,414,242 | 12,190 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,085,991 | 14,455 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,770,543 | 14,575 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,086,820 | 14,482 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,530,740 | 16,227 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,712,816 | 15,127 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,167,633 | 15,990 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,660,907 | 17,569 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,600,353 | 17,924 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,113,779 | 17,986 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,467,771 | 18,984 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,838,755 | 18,004 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $3,907,774 | 17,601 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $3,399,972 | 14,064 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,704,011 | 14,103 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,158,981 | 14,015 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,446,587 | 14,166 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,572,165 | 14,772 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $3,386,248 | 15,052 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,395,595 | 15,968 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $4,053,318 | 16,629 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,379,802 | 17,603 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $4,018,081 | 17,476 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,463,303 | 17,561 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,203,732 | 17,823 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $3,666,980 | 18,088 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||